Allergan Investor Suit Over Botox Deal Put On Hold
A judge stayed proceedings Friday in an Allergan Inc. shareholder derivative suit seeking to force the company's board to cover a $600 million settlement with the U.S. over off-label Botox uses,...To view the full article, register now.
Already a subscriber? Click here to view full article